Tirzepatide for obesity and type 2 diabetes
Part of Hormones & metabolism clinical trials.
This study looks at how well the medicine tirzepatide works in real life for adults who are overweight (BMI 30 or more) and have prediabetes or type 2 diabetes. It aims to see if the medicine helps control blood sugar and weight, and it's important that you have had a recent eye exam before starting.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older
- You must have a BMI of 30 or higher
- You must have prediabetes or type 2 diabetes
- You must not have taken tirzepatide before
- If you took other similar diabetes medicines (like Ozempic) recently, you need to have stopped them at least 8 weeks before starting
- You must have had a recent eye exam (to check for diabetic eye problems)
- You must not be pregnant, breastfeeding, or have severe kidney disease (eGFR less than 30)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether tirzepatide, a medication that helps with weight loss and blood sugar control, can improve the ability to exercise and daily function in people who have heart failure with reduced pumping strength and are overweight or obese.
This study tests whether the medicine tirzepatide can help adults who are overweight or obese and have congenital heart disease (a heart condition present from birth) lose weight safely. The medicine may also improve heart health and metabolism. It is for people who have already tried diet and exercise for at least a year without much weight loss.
This study tests a medication called tirzepatide for people with type 1 diabetes who also have overweight or obesity. Tirzepatide may help with weight loss and blood sugar control, and you'll use a continuous glucose monitor throughout the study.
This study tests a medicine called tirzepatide to see if it helps people with overweight or obesity lose weight, whether or not they also have type 2 diabetes. Tirzepatide is given as an injection and works on hormones that control appetite.
This study tests a once-weekly medicine called tirzepatide to see if it helps control blood sugar and reduce weight in people with type 2 diabetes and obesity. If you qualify, you might get this treatment and be monitored for safety and satisfaction.
This trial tests if tirzepatide is more effective than standard obesity treatments for adults who have a BMI between 30 and 35 and one weight-related health condition, but do not have diabetes. The goal is to help you lose weight.
Hear when a new Obesity Type 2 Diabetes Mellitus trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.